|
DK0656789T3
(da)
*
|
1992-08-21 |
1998-08-24 |
Genentech Inc |
Fremgangsmåde til behandling af en LFA-1-medieretforstyrrelse.
|
|
FR2700471B1
(fr)
*
|
1993-01-21 |
1995-04-07 |
Pasteur Merieux Serums Vacc |
Utilisation d'anticorps monoclonaux anti-LFA-1 pour la préparation d'un médicament destiné à prévenir le rejet des greffes d'organes solides et médicaments obtenus.
|
|
US6884590B1
(en)
|
1994-02-11 |
2005-04-26 |
Cedars-Sinai Medical Center |
Methods of screening for ulcerative colitis and crohn's disease
|
|
US5681699A
(en)
*
|
1994-02-11 |
1997-10-28 |
Cedars-Sinai Medical Center |
Methods of diagnosing ulcerative colitis and Crohn's disease
|
|
US6576236B1
(en)
*
|
1994-07-01 |
2003-06-10 |
Dana Farber Cancer Institute |
Methods for stimulating T cell responses by manipulating a common cytokine receptor γ chain
|
|
US20020127201A1
(en)
*
|
1994-07-01 |
2002-09-12 |
Dana-Farber Cancer Institute. |
Methods for inhibiting T cell responses by manipulating a common cytokine receptor gamma-chain
|
|
AU6256796A
(en)
*
|
1995-06-06 |
1996-12-24 |
D. Allen Allen |
Method for treating molluscum contagiosum resulting from hiv infection
|
|
US20040197326A1
(en)
*
|
1995-07-27 |
2004-10-07 |
Genentech, Inc. |
Method for treatment of allergic asthma
|
|
US5914112A
(en)
*
|
1996-01-23 |
1999-06-22 |
Genentech, Inc. |
Anti-CD18 antibodies in stroke
|
|
AU5140196A
(en)
*
|
1996-03-29 |
1997-10-22 |
Universite Laval |
Method of restoring a functional protein in a tissue by cell transplantation
|
|
US6037454A
(en)
|
1996-11-27 |
2000-03-14 |
Genentech, Inc. |
Humanized anti-CD11a antibodies
|
|
US7122636B1
(en)
*
|
1997-02-21 |
2006-10-17 |
Genentech, Inc. |
Antibody fragment-polymer conjugates and uses of same
|
|
FR2763072B1
(fr)
*
|
1997-05-12 |
1999-11-05 |
Pasteur Merieux Serums Vacc |
Utilisation d'un anticorps monoclonal anti-lfa1 en transplantation renale
|
|
WO1998052606A1
(en)
*
|
1997-05-17 |
1998-11-26 |
Biogen, Inc. |
Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
|
|
US6172213B1
(en)
*
|
1997-07-02 |
2001-01-09 |
Genentech, Inc. |
Anti-IgE antibodies and method of improving polypeptides
|
|
WO2000029431A1
(en)
*
|
1998-11-17 |
2000-05-25 |
Tanox, Inc. |
Bispecific molecules cross-linking itim and itam for therapy
|
|
US6867203B2
(en)
|
1998-12-29 |
2005-03-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
|
|
US6582698B1
(en)
|
1999-03-19 |
2003-06-24 |
Genentech, Inc. |
Treatment method
|
|
EP1854480A3
(en)
|
1999-03-19 |
2009-04-01 |
Genentech, Inc. |
Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
|
|
EP1237575B1
(en)
*
|
1999-12-14 |
2008-08-06 |
Genentech, Inc. |
Tnf-alpha antagonist and lfa-1 antagonist for treating rheumatoid arthritis
|
|
AU2001230920A1
(en)
*
|
2000-01-14 |
2001-07-24 |
Genentech Inc. |
Diagnosis and treatment of hepatic inflammatory disorders by inhibiting the binding of lfa-1 to icam-1
|
|
AU4574501A
(en)
|
2000-03-17 |
2001-10-03 |
Millennium Pharm Inc |
Method of inhibiting stenosis and restenosis
|
|
ATE448306T1
(de)
|
2000-09-01 |
2009-11-15 |
Blood Res Center |
Veränderte, in gewünschter konformation stabilisierte polypeptide und verfahren zu deren herstellung
|
|
CA2451517C
(en)
|
2001-06-22 |
2011-05-03 |
Pioneer Hi-Bred International, Inc. |
Defensin polynucleotides and methods of use
|
|
ATE417858T1
(de)
|
2002-02-05 |
2009-01-15 |
Genentech Inc |
Proteinaufreinigung
|
|
AU2003265235A1
(en)
*
|
2002-04-26 |
2003-12-19 |
Genetech, Inc. |
Non-affinity purification of proteins
|
|
ES2575547T3
(es)
|
2003-02-01 |
2016-06-29 |
Tanox, Inc. |
Anticuerpos anti-IgE de humano de alta afinidad
|
|
US7834147B2
(en)
|
2003-04-28 |
2010-11-16 |
Childrens Hospital Medical Center |
Saposin C-DOPS: a novel anti-tumor agent
|
|
PT3095793T
(pt)
|
2003-07-28 |
2020-05-04 |
Genentech Inc |
Redução da lixiviação de proteína a durante a cromatografia por afinidade com proteína a
|
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
|
CN105820160B
(zh)
|
2003-11-05 |
2019-02-12 |
萨可德生物科学公司 |
细胞粘着调节剂
|
|
EP2264191A1
(en)
|
2003-11-21 |
2010-12-22 |
ANP Technologies, Inc. |
Asymmetrically branched polymer conjugates and microarray assays
|
|
AU2005244751A1
(en)
*
|
2004-04-16 |
2005-12-01 |
Genentech, Inc. |
Method for augmenting B cell depletion
|
|
BRPI0511305A
(pt)
*
|
2004-06-09 |
2007-12-04 |
Genentech Inc |
método de aliviar um granuloma anular ou sarcóide, artigo manufaturado e uso de um antagonista de lfa-1
|
|
US7655229B2
(en)
*
|
2004-09-02 |
2010-02-02 |
Chan Andrew C |
Anti-FC-gamma RIIB receptor antibody and uses therefor
|
|
US7662926B2
(en)
*
|
2004-09-02 |
2010-02-16 |
Genentech, Inc. |
Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor
|
|
AU2005282720B2
(en)
*
|
2004-09-02 |
2011-08-04 |
Genentech, Inc. |
Anti-FC-gamma RIIB receptor antibody and uses therefor
|
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
DE102004059357B8
(de)
*
|
2004-12-03 |
2009-12-03 |
Universität Leipzig |
Antikörper, welcher die Interaktion von humanem Thy-1 und dessen Liganden blockiert, sowie dessen Verwendung
|
|
US8563329B2
(en)
|
2005-05-02 |
2013-10-22 |
Anp Technologies, Inc. |
Polymer conjugate enhanced bioassays
|
|
PL2444079T3
(pl)
|
2005-05-17 |
2017-07-31 |
Sarcode Bioscience Inc. |
Kompozycje i sposoby leczenia chorób oczu
|
|
KR20080112300A
(ko)
*
|
2006-03-16 |
2008-12-24 |
제넨테크, 인크. |
Ｃｄ4 항체를 사용하여 루푸스를 치료하는 방법
|
|
US20080279848A1
(en)
*
|
2006-03-16 |
2008-11-13 |
Genentech, Inc. |
Methods of treating lupus using CD4 antibodies
|
|
FR2902799B1
(fr)
|
2006-06-27 |
2012-10-26 |
Millipore Corp |
Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
|
|
WO2008011081A2
(en)
|
2006-07-19 |
2008-01-24 |
The Trustees Of The University Of Pennsylvania |
Wsx-1/p28 as a target for anti-inflammatory responses
|
|
SI2097455T1
(sl)
|
2006-11-02 |
2015-03-31 |
Genentech, Inc. |
Humanizirana protitelesa proti faktorju tipa d
|
|
US8362217B2
(en)
|
2006-12-21 |
2013-01-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
US8163886B2
(en)
*
|
2006-12-21 |
2012-04-24 |
Emd Millipore Corporation |
Purification of proteins
|
|
US8569464B2
(en)
*
|
2006-12-21 |
2013-10-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
MX2009007632A
(es)
|
2007-01-22 |
2009-07-24 |
Genentech Inc |
Precipitacion de polielectrolito y purificacion de proteinas.
|
|
EP1995309A1
(en)
*
|
2007-05-21 |
2008-11-26 |
Vivalis |
Recombinant protein production in avian EBx® cells
|
|
MX354993B
(es)
|
2007-07-09 |
2018-03-28 |
Genentech Inc |
Prevención de reducción de enlaces de disulfuro durante la producción recombinante de polipéptidos.
|
|
CA2702984C
(en)
*
|
2007-10-19 |
2017-04-11 |
Sarcode Corporation |
Compositions and methods for treatment of diabetic retinopathy
|
|
BRPI0817182A2
(pt)
|
2007-10-30 |
2015-03-17 |
Genentech Inc |
Método para purificar um anticorpo e composições
|
|
US20090257957A1
(en)
*
|
2008-04-15 |
2009-10-15 |
John Burnier |
Aerosolized LFA-1 antagonists for use in localized treatment of immune related disorders
|
|
WO2009139817A2
(en)
|
2008-04-15 |
2009-11-19 |
Sarcode Corporation |
Crystalline pharmaceutical and methods of preparation and use thereof
|
|
WO2009128932A1
(en)
*
|
2008-04-15 |
2009-10-22 |
Sarcode Corporation |
Delivery of lfa-1 antagonists to the gastrointestinal system
|
|
EP3632444A3
(en)
|
2008-04-15 |
2020-08-26 |
SARcode Bioscience Inc. |
Topical lfa-1 antagonists for use in localized treatment of immune related disorders
|
|
CR20170001A
(es)
|
2008-04-28 |
2017-08-10 |
Genentech Inc |
Anticuerpos anti factor d humanizados
|
|
WO2009151514A1
(en)
*
|
2008-06-11 |
2009-12-17 |
Millipore Corporation |
Stirred tank bioreactor
|
|
WO2010009129A2
(en)
*
|
2008-07-15 |
2010-01-21 |
Genentech, Inc. |
Methods of treating autoimmune diseases using cd4 antibodies
|
|
CN102149724B
(zh)
|
2008-08-14 |
2014-04-09 |
健泰科生物技术公司 |
使用原地蛋白质置换离子交换膜层析清除污染物的方法
|
|
CA2734275A1
(en)
|
2008-09-10 |
2010-03-18 |
Genentech, Inc. |
Compositions and methods for the prevention of oxidative degradation of proteins
|
|
US20110229471A1
(en)
|
2008-11-26 |
2011-09-22 |
Cedars-Sinai Medical Center |
Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
|
|
CN102257122B
(zh)
|
2008-12-16 |
2015-07-29 |
Emd密理博公司 |
搅拌槽反应器及方法
|
|
US20110020327A1
(en)
*
|
2008-12-16 |
2011-01-27 |
Millipore Corporation |
Purification of proteins
|
|
US9580752B2
(en)
|
2008-12-24 |
2017-02-28 |
Cedars-Sinai Medical Center |
Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
|
|
CN102333548B
(zh)
|
2009-02-27 |
2013-01-30 |
健泰科生物技术公司 |
用于蛋白质标记的方法和组合物
|
|
BR112012002974B1
(pt)
|
2009-08-11 |
2022-06-07 |
Genentech, Inc |
Processo para produzir um anticorpo em uma célula hospedeira de célula ovário de hamster chinês (cho) expressando o referido polipeptídeo
|
|
KR101764449B1
(ko)
|
2009-09-01 |
2017-08-02 |
제넨테크, 인크. |
변형된 단백질 ａ 용리를 통한 증진된 단백질 정제
|
|
WO2011050175A1
(en)
|
2009-10-21 |
2011-04-28 |
Sarcode Corporation |
Crystalline pharmaceutical and methods of preparation and use thereof
|
|
US20120309056A1
(en)
|
2010-02-04 |
2012-12-06 |
Leon Arnaud |
Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
|
|
CN106983862A
(zh)
|
2010-03-22 |
2017-07-28 |
弗·哈夫曼-拉罗切有限公司 |
对于稳定含有蛋白质的制剂有用的组合物和方法
|
|
PT3178851T
(pt)
|
2010-03-31 |
2020-07-17 |
Boehringer Ingelheim Int |
Anticorpos anti-cd40
|
|
EP3372617B1
(en)
|
2010-04-02 |
2024-07-24 |
Amunix Pharmaceuticals, Inc. |
Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
|
|
RU2012151500A
(ru)
|
2010-05-03 |
2014-06-10 |
Дженентек, Инк. |
Композиции и способы, пригодные для снижения вязкости белковосодержащих составов
|
|
DK2571903T3
(da)
|
2010-05-17 |
2019-11-04 |
Emd Millipore Corp |
Polymerer, der reagerer på stimuli, til oprensning af biomolekyler
|
|
PL2576580T3
(pl)
|
2010-05-28 |
2017-03-31 |
F.Hoffmann-La Roche Ag |
Zmniejszenie poziomu mleczanu i zwiększenie wytwarzania polipeptydu przez obniżenie poziomu ekspresji dehydrogenazy mleczanowej i kinazy dehydrogenazy pirogronianowej
|
|
MY184736A
(en)
|
2010-06-24 |
2021-04-20 |
Genentech Inc |
Compositions and methods containing alkylglycosides for stabilizing protein-containing formulations
|
|
CN104474546A
(zh)
|
2010-08-13 |
2015-04-01 |
弗·哈夫曼-拉罗切有限公司 |
用于疾病治疗的针对IL-1β和IL-18的抗体
|
|
BR112013003223A2
(pt)
|
2010-08-23 |
2016-06-07 |
Pioneer Hi Bred Int |
"polinucleotídeo isolado, cassete de expressão, célula hospedeira, micro-organismo, planta ou parte de planta, método de obtenção de uma planta transformada, composição antipatogênica, método para proteger uma planta contra um patógeno ou uso de um polinucleotídeo isolado"
|
|
WO2012030512A1
(en)
|
2010-09-03 |
2012-03-08 |
Percivia Llc. |
Flow-through protein purification process
|
|
SG190006A1
(en)
|
2010-11-04 |
2013-06-28 |
Boehringer Ingelheim Int |
Anti-il-23 antibodies
|
|
CN103429267B
(zh)
|
2011-01-09 |
2016-05-04 |
Anp科技公司 |
疏水分子诱导的支化聚合物集合体及其用途
|
|
WO2012095514A1
(en)
|
2011-01-14 |
2012-07-19 |
Vivalis |
Recombinant protein production system
|
|
CN107827985A
(zh)
|
2011-05-21 |
2018-03-23 |
宏观基因有限公司 |
能够与人和非人cd3结合的cd3结合分子
|
|
SG194763A1
(en)
|
2011-07-08 |
2013-12-30 |
Emd Millipore Corp |
Improved depth filters for disposable biotechnological processes
|
|
FI3536710T3
(fi)
|
2011-11-16 |
2026-01-14 |
Boehringer Ingelheim Int |
Anti-il-36r -vasta-aineita
|
|
HRP20181846T1
(hr)
|
2011-12-22 |
2018-12-28 |
Genentech, Inc. |
Kromatografija membranom za ionsku izmjenu
|
|
SG10202007206WA
(en)
|
2012-03-27 |
2020-08-28 |
Genentech Inc |
Improved harvest operations for recombinant proteins
|
|
NZ700802A
(en)
|
2012-05-03 |
2017-06-30 |
Boehringer Ingelheim Int |
Anti-il-23p19 antibodies
|
|
AU2013262611B2
(en)
|
2012-05-18 |
2018-03-01 |
Genentech, Inc. |
High-concentration monoclonal antibody formulations
|
|
RU2658015C2
(ru)
|
2012-07-25 |
2018-06-19 |
Саркоуд Байосайенс Инк. |
Ингибитор ассоциированного с функцией лимфоцитов антигена-1 (lfa-1), способы его получения и его полиморф
|
|
WO2014078522A1
(en)
|
2012-11-14 |
2014-05-22 |
Ohio State Innovation Foundation |
Materials and methods useful for treating glioblastoma
|
|
CN104994885B
(zh)
|
2012-12-19 |
2017-09-29 |
基因泰克公司 |
用于放射性卤素蛋白质标记的方法和组合物
|
|
AU2014215555B2
(en)
|
2013-02-05 |
2018-05-17 |
Anp Technologies, Inc. |
Nanoparticles containing a taxane and their use
|
|
JO3529B1
(ar)
|
2013-02-08 |
2020-07-05 |
Amgen Res Munich Gmbh |
مضاد التصاق خلايا الدم البيض من أجل التخفيف من الاثار السلبية الممكنة الناتجة عن مجالات ارتباط cd3- المحدد
|
|
KR20240122922A
(ko)
|
2013-03-27 |
2024-08-13 |
세다르스-신나이 메디칼 센터 |
Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한 섬유증 및 염증의 완화 및 반전
|
|
EP4105236A1
(en)
|
2013-07-19 |
2022-12-21 |
Cedars-Sinai Medical Center |
Anti-tl1a (tnfsf15) antibody for treatment of inflammatory bowel disease
|
|
CA2920666A1
(en)
|
2013-08-12 |
2015-02-19 |
Genentech, Inc. |
Compositions and method for treating complement-associated conditions
|
|
EA033604B1
(ru)
|
2014-01-31 |
2019-11-08 |
Boehringer Ingelheim Int |
Молекула анти-baff антитела, фармацевтическая композиция, содержащая эту молекулу, способы ее применения и кодирующий ее изолированный полинуклеотид
|
|
CR20160561A
(es)
|
2014-05-01 |
2017-05-03 |
Genentech Inc |
Variantes del anticuerpo anti-factor d y sus usos
|
|
EP3166401B1
(en)
|
2014-07-09 |
2020-08-19 |
F. Hoffmann-La Roche AG |
Ph adjustment to improve thaw recovery of cell banks
|
|
EP3708679A1
(en)
|
2014-07-24 |
2020-09-16 |
Boehringer Ingelheim International GmbH |
Biomarkers useful in the treatment of il-23a related diseases
|
|
IL321788A
(en)
|
2015-02-04 |
2025-08-01 |
Boehringer Ingelheim Int |
Methods of treating inflammatory diseases
|
|
CA2993996A1
(en)
|
2015-09-01 |
2017-03-09 |
Boehringer Ingelheim International Gmbh |
Use of anti-cd40 antibodies for treatment of lupus nephritis
|
|
KR20250007054A
(ko)
|
2015-09-04 |
2025-01-13 |
프리마토프 테라퓨틱스 인크. |
인간화 항-cd40 항체 및 그의 용도
|
|
US10654932B2
(en)
|
2015-10-30 |
2020-05-19 |
Genentech, Inc. |
Anti-factor D antibody variant conjugates and uses thereof
|
|
US10407510B2
(en)
|
2015-10-30 |
2019-09-10 |
Genentech, Inc. |
Anti-factor D antibodies and conjugates
|
|
CN109462996A
(zh)
|
2016-03-17 |
2019-03-12 |
西达-赛奈医疗中心 |
通过rnaset2诊断炎性肠病的方法
|
|
KR20190012145A
(ko)
|
2016-03-29 |
2019-02-08 |
젤터, 인코포레이티드 |
주변세포질 부피 대 세포질 부피의 비가 0.5:1 내지 10:1인 그람-음성 박테리아에서의 단백질의 발현
|
|
AU2017382281B2
(en)
|
2016-12-22 |
2024-07-11 |
Genentech, Inc. |
Methods and formulations for reducing reconstitution time of lyophilized polypeptides
|
|
JP2020512344A
(ja)
|
2017-03-27 |
2020-04-23 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
抗ｉｌ−３６ｒ抗体併用治療
|
|
US11180541B2
(en)
|
2017-09-28 |
2021-11-23 |
Geltor, Inc. |
Recombinant collagen and elastin molecules and uses thereof
|
|
JP7504808B2
(ja)
|
2018-06-29 |
2024-06-24 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
自己免疫疾患の処置における使用のための抗ｃｄ４０抗体
|
|
EP4368699A3
(en)
|
2018-07-03 |
2024-09-11 |
Bristol-Myers Squibb Company |
Methods of producing recombinant proteins
|
|
WO2020076776A1
(en)
|
2018-10-10 |
2020-04-16 |
Boehringer Ingelheim International Gmbh |
Method for membrane gas transfer in high density bioreactor culture
|
|
KR20210137520A
(ko)
|
2019-03-08 |
2021-11-17 |
베링거 인겔하임 인터내셔날 게엠베하 |
항-il-36r 항체 제형
|
|
AR118536A1
(es)
|
2019-04-01 |
2021-10-20 |
Genentech Inc |
Composiciones y métodos para estabilizar formulaciones que contienen proteína
|
|
GB2597416A
(en)
|
2019-04-12 |
2022-01-26 |
Geltor Inc |
Recombinant elastin and production thereof
|
|
US20220315887A1
(en)
|
2019-08-01 |
2022-10-06 |
Bristol-Myers Squibb Company |
Methods of improving protein productivity in fed-batch cell cultures
|
|
TW202535466A
(zh)
|
2019-09-09 |
2025-09-16 |
德商百靈佳殷格翰國際股份有限公司 |
抗-il-23p19抗體調配物
|
|
US11999787B2
(en)
|
2020-03-24 |
2024-06-04 |
Genentech, Inc. |
Tie2-binding agents and methods of use
|
|
JP2023542678A
(ja)
|
2020-09-21 |
2023-10-11 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
炎症状態の処置のための抗ｃｄ４０抗体の使用。
|
|
JP7808097B2
(ja)
|
2020-09-22 |
2026-01-28 |
ブリストル－マイヤーズ スクイブ カンパニー |
治療タンパク質を生産するための方法
|
|
WO2022170008A2
(en)
|
2021-02-05 |
2022-08-11 |
Boehringer Ingelheim International Gmbh |
Anti-il1rap antibodies
|
|
WO2023015234A1
(en)
|
2021-08-05 |
2023-02-09 |
Bristol-Myers Squibb Company |
Cell culture methods for producing therapeutic proteins
|
|
US20240390869A1
(en)
|
2021-09-21 |
2024-11-28 |
Bristol-Myers Squibb Company |
Methods of controlling the level of dissolved oxygen (do) in a solution comprising a recombinant protein in a storage container
|